1/18/2022 1:12:31 AM
Molecular Partners Finalizes License Deal With Novartis For Ensovibep For COVID-19
1/10/2022 1:42:59 AM
Molecular Partners, Novartis Report Positive Topline Data From Phase 2 Study For Ensovibep
12/14/2021 1:07:51 AM
Molecular Partners Collaborates With Novartis To Develop DARPin Platform With Novartis’ In Radioligand Therapy